M. Shirley

发表

RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation

D. Ruddy, C. Voliva, Alyson K. Freeman, 2021, Molecular Cancer Research.

PISCES: a package for rapid quantitation and quality control of large scale mRNA-seq datasets

Joshua M. Korn, Matthew D. Shirley, Viveksagar K. Radhakrishna, 2020, bioRxiv.

Unexpected Relationships and Inbreeding in HapMap Phase III Populations

Matthew D. Shirley, Joseph D. Baugher, J. Pevsner, 2012, PloS one.

Copy Number Variants Associated with 14 Cases of Self-Injurious Behavior

L. Hagopian, W. Silverman, J. Pevsner, 2016, PloS one.

Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Matthew D. Shirley, Joseph D. Baugher, B. Cohen, 2013, The New England journal of medicine.

In-Depth Characterization and Validation in BRG1-Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin Remodeling

Joshua M. Korn, W. Sellers, J. Korn, 2019, bioRxiv.

CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.

Joshua M. Korn, Eric Billy, Tobias Schmelzle, 2016, Cancer discovery.

Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma

J. Engelman, D. Ruddy, Alyson K. Freeman, 2018, Molecular Cancer Research.

The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma

A. Kauffmann, D. Ruddy, GiNell Elliott, 2020, Molecular Cancer Therapeutics.

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

R. Carvajal, S. Piperno-Neumann, M. Carlino, 2023, British Journal of Cancer.

Sensitive and specific detection of mosaic chromosomal abnormalities using the Parent-of-Origin-based Detection (POD) method

Joseph D. Baugher, J. Pevsner, M. Shirley, 2013, BMC Genomics.

Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment

Matthew D. Shirley, Hao Wang, P. Hammerman, 2021, Cancer Research.

Chromosomal variation in lymphoblastoid cell lines

Jonathan Pevsner, Joseph D. Baugher, Joseph D Baugher, 2012, Human mutation.

Concerns regarding "Whole exome sequencing reveals minimal differences between cell line and whole blood derived DNA".

M. Shirley, 2013, Genomics.

Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

P. Hammerman, G. Caponigro, S. Silver, 2019, Molecular Cancer Therapeutics.

Sensitive and specific detection of mosaic chromosomal abnormalities using the Parent-of-Origin-based Detection (POD) method

Matthew D. Shirley, Joseph D. Baugher, J. Pevsner, 2013, BMC Genomics.

INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas

D. Ruddy, N. Ebel, S. Maira, 2024, Nature cancer.